Patricia Zane

969 total citations
15 papers, 474 citations indexed

About

Patricia Zane is a scholar working on Pharmaceutical Science, Molecular Biology and Spectroscopy. According to data from OpenAlex, Patricia Zane has authored 15 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 3 papers in Spectroscopy. Recurrent topics in Patricia Zane's work include Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Patricia Zane is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Patricia Zane collaborates with scholars based in United States, Germany and France. Patricia Zane's co-authors include Valérie Boutet, Eric Woolf, Ronald de Vries, Karen Woods, Philip Denniff, Mark E. Arnold, Qin Ji, Yang Xu, James Rudge and Neil Spooner and has published in prestigious journals such as Cellular and Molecular Life Sciences, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Patricia Zane

15 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Zane United States	11	185	112	104	83	69	15	474
Ragini Vuppugalla United States	16	81 0.4×	40 0.4×	214 2.1×	36 0.4×	90 1.3×	27	898
Naiyu Zheng United States	18	131 0.7×	17 0.2×	336 3.2×	61 0.7×	65 0.9×	39	695
Stephanie A. Sweetana United States	10	25 0.1×	161 1.4×	115 1.1×	20 0.2×	32 0.5×	12	531
Suresh P. Sulochana India	13	57 0.3×	23 0.2×	170 1.6×	25 0.3×	89 1.3×	60	472
I. Gardner United Kingdom	10	43 0.2×	17 0.2×	133 1.3×	25 0.3×	67 1.0×	17	510
Frank W. Lee United States	13	28 0.2×	29 0.3×	173 1.7×	32 0.4×	74 1.1×	21	698
William Hageman United States	13	43 0.2×	28 0.3×	212 2.0×	33 0.4×	63 0.9×	33	610
David M. Ritchie United States	14	46 0.2×	26 0.2×	167 1.6×	28 0.3×	95 1.4×	23	573
Serge Guzy United States	9	31 0.2×	31 0.3×	80 0.8×	27 0.3×	55 0.8×	27	305
Brian Rago United States	15	59 0.3×	44 0.4×	159 1.5×	39 0.5×	25 0.4×	20	525

Countries citing papers authored by Patricia Zane

Since Specialization

Citations

This map shows the geographic impact of Patricia Zane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Zane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Zane more than expected).

Fields of papers citing papers by Patricia Zane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Zane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Zane. The network helps show where Patricia Zane may publish in the future.

Co-authorship network of co-authors of Patricia Zane

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Zane. A scholar is included among the top collaborators of Patricia Zane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Zane. Patricia Zane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Abrahamsson, Bertil, Mark McAllister, Patrick Augustijns, et al.. (2020). Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project. European Journal of Pharmaceutics and Biopharmaceutics. 152. 236–247. 19 indexed citations

Watanabe, Ayahisa, et al.. (2019). In-vitro–in-silico investigation of the negative food effect of zolpidem when administered as immediate-release tablets. Journal of Pharmacy and Pharmacology. 71(11). 1663–1676. 8 indexed citations

Zane, Patricia, Hille Gieschen, Neil Mathias, et al.. (2019). In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development. European Journal of Pharmaceutics and Biopharmaceutics. 142. 222–231. 19 indexed citations

Lennernäs, Hans, Anders Lindahl, A. Van Peer, et al.. (2017). In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context. Molecular Pharmaceutics. 14(4). 1307–1314. 44 indexed citations

Derdau, Volker, et al.. (2015). Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638. Bioorganic & Medicinal Chemistry. 23(13). 3831–3842. 21 indexed citations

Spooner, Neil, Philip Denniff, Ronald de Vries, et al.. (2014). A Device for Dried Blood Microsampling in Quantitative Bioanalysis: Overcoming The Issues Associated Blood Hematocrit. Bioanalysis. 7(6). 653–659. 184 indexed citations

Zane, Patricia, et al.. (2013). Use of the pentagastrin dog model to explore the food effects on formulations in early drug development. European Journal of Pharmaceutical Sciences. 57. 207–213. 18 indexed citations

Zane, Patricia & Gary T Emmons. (2013). Microsampling in Pharmaceutical Bioanalysis. 6 indexed citations

Guo, Zuyu, et al.. (2010). Impact of Various Factors on Radioactivity Distribution in Different DBS Papers. Bioanalysis. 2(8). 1469–1475. 54 indexed citations

10.

Cohen, David S., et al.. (1999). CGS 30440: A Dual Inhibitor of Angiotensin‐Converting Enzyme and Neutral Endopeptidase 24.11. Cardiovascular Drug Reviews. 17(1). 16–38. 7 indexed citations

11.

Zane, Patricia, et al.. (1997). Validation of Procedures for Quantitative Whole-Body Autoradiography using Digital Imaging. Journal of Pharmaceutical Sciences. 86(6). 733–738. 14 indexed citations

12.

Chovan, James P., et al.. (1992). Automated-extraction, high-performance liquid chromatographic method and pharmacokinetics in rats of a highly A2-selective adenosine agonist, CGS 21680. Journal of Chromatography B Biomedical Sciences and Applications. 578(1). 77–83. 14 indexed citations

13.

Cohen, David S., Donald N. McMartin, M. Marietta, Patricia Zane, & Rodney W. Lappe. (1992). CGS 22652: A New Potent Thromboxane A₂ Receptor Antagonist with Selective Thromboxane A₂ Synthase Inhibitory Properties. Cardiovascular Drug Reviews. 10(4). 379–391. 6 indexed citations

14.

Zane, Patricia, et al.. (1990). Physicochemical Factors Associated with Binding and Retention of Compounds in Ocular Melanin of Rats: Correlations Using Data from Whole-Body Autoradiography and Molecular Modeling for Multiple Linear Regression Analyses. Pharmaceutical Research. 7(9). 935–941. 36 indexed citations

15.

Zane, Patricia, et al.. (1990). Calculation of drug-melanin binding energy using molecular modeling. Cellular and Molecular Life Sciences. 46(1). 77–80. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact